Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

ardeparin

Known as: ardeparin [Chemical/Ingredient] 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2006
2006
Low molecular weight heparin (LMWH) is the agent of choice for anticoagulant therapy and prophylaxis of thrombosis and coronary… Expand
2006
2006
L‐Arginine is the principal physiological precursor of nitric oxide (NO, a key neurotransmitter) that plays a versatile role in… Expand
1999
1999
In addition to its anticoagulant effects, heparin is known to have antiproliferative effects on vascular smooth muscle cells… Expand
1999
1999
  • R. Bick, J. Fareed
  • Clinical and applied thrombosis/hemostasis…
  • 1999
  • Corpus ID: 24581827
There is adequate preclinical data to support the differential biochemical and pharmacological behavior of the currently approved… Expand
  • figure 3
  • figure 1
  • figure 2
  • figure 4
  • figure 5
Highly Cited
1996
Highly Cited
1996
BACKGROUND Deep vein thrombosis is common in patients undergoing major knee surgery. Static graduated compression stockings… Expand
Highly Cited
1995
Highly Cited
1995
Osteoporosis is a well-recognized complication of long-term heparin use. However, the mechanisms by which heparin can influence… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 6
1995
1995
Tissue factor pathway inhibitor (TFPI) is an important mediator of the in vivo anticoagulant/antithrombotic properties of… Expand
Highly Cited
1994
Highly Cited
1994
We have compared the non-specific binding of unfractionated heparin (UFH) with that of low molecular weight heparin (LMWH) to… Expand